ArticleBlood cancer journal2023

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.

Miao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.